---
title: "Maanshan Iron & Steel Expects Sharply Narrowed 2025 Loss Amid Tough Steel Market"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274152067.md"
description: "Maanshan Iron & Steel Co (HK:0323) forecasts a narrowed net loss of RMB250 million to RMB190 million for 2025, significantly down from a RMB4.659 billion loss last year. The company attributes this improvement to reforms, cost controls, and a shift towards higher-end products, despite ongoing challenges in China's steel market. The latest analyst rating for the stock is a Hold with a price target of HK$2.50. Maanshan Iron & Steel is focused on enhancing competitiveness through efficiency improvements and product optimization amid industry adjustments."
datetime: "2026-01-29T12:43:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274152067.md)
  - [en](https://longbridge.com/en/news/274152067.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274152067.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274152067.md) | [繁體中文](https://longbridge.com/zh-HK/news/274152067.md)


# Maanshan Iron & Steel Expects Sharply Narrowed 2025 Loss Amid Tough Steel Market

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Maanshan Iron & Steel Co ( (HK:0323) ) just unveiled an update.

Maanshan Iron & Steel has issued an earnings alert for 2025, forecasting total profit of RMB120 million to RMB180 million but a net loss attributable to shareholders of between RMB250 million and RMB190 million, a substantial narrowing from the RMB4.659 billion loss recorded a year earlier. The company attributes the improved results to ongoing reforms, tighter cost controls, optimisation of its product mix toward higher-end offerings, and operational support from Baoshan Iron & Steel, which collectively strengthened cost competitiveness and operating performance across the group. However, persistent supply-demand imbalances in China’s steel market, pressure on steel prices, volatile raw material costs, fourth-quarter market fluctuations and weaker performance at some partially owned subsidiaries mean the company remains in a transitional phase and has not yet returned to full-year profitability, underscoring the challenging environment facing the domestic steel industry even as losses sharply narrow for stakeholders.

The most recent analyst rating on (HK:0323) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Maanshan Iron & Steel Co stock, see the HK:0323 Stock Forecast page.

**More about Maanshan Iron & Steel Co**

Maanshan Iron & Steel Company Limited is a major Chinese steel producer, operating in the iron and steel industry with a focus on pre-steelmaking and steel rolling systems, as well as high-end steel products. The group includes subsidiaries such as Maanshan Iron & Steel Limited Company and Anhui Changjiang Steel Co., Ltd., and has been working on cost reduction, product mix optimisation and efficiency improvements to enhance its competitiveness amid ongoing capacity cuts and structural adjustments in China’s steel sector.

**Average Trading Volume:** 14,360,094

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$34.05B

Learn more about 0323 stock on TipRanks’ Stock Analysis page.

### 相关股票

- [MAANSHAN IRON (00323.HK)](https://longbridge.com/zh-CN/quote/00323.HK.md)
- [Guotai CSI Iron & Steel ETF (515210.CN)](https://longbridge.com/zh-CN/quote/515210.CN.md)

## 相关资讯与研究

- [Chongqing Iron & Steel Shareholders Approve All Resolutions, Whitewash Waiver Granted](https://longbridge.com/zh-CN/news/279062450.md)
- [Iron ore climbs as Hebei mills resume output; auto weakness caps upside](https://longbridge.com/zh-CN/news/278816100.md)
- [JSW Steel unit eyes debut $1 billion shorter-duration debt issue, bankers say](https://longbridge.com/zh-CN/news/279199455.md)
- [This Steel Stock Just Hiked its Dividend by 6%, Is it a Buy Now?](https://longbridge.com/zh-CN/news/278764890.md)
- [Kontafarma Warns of Wider Losses for 2025](https://longbridge.com/zh-CN/news/278827704.md)